Global Botulinum Toxin Market 2022-2028
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global botulinum toxin market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the botulinum toxin industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for botulinum toxin can be segmented By product type A botulinum toxin, type B botulinum toxin. Botulinum toxin market is further segmented By applicationt aesthetic, medical. Based on end user, the botulinum toxin market is segmented into: hospitals, specialty and dermatology clinics, others. On the basis of region, the botulinum toxin market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product:
- type A botulinum toxin
- type B botulinum toxin
By applicationt:
- aesthetic
- medical
By end user:- hospitals
- specialty and dermatology clinics
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The aesthetic application market is further segmented into forehead lines, glabellar lines, lateral canthal lines (crows feet), others. Furthermore, the medical application market has been categorized into chronic migraine, hyperhidrosis, muscle spasm, over reactive bladder, others.
The report also provides analysis of the key companies of the industry and their detailed company profiles including AbbVie Inc. (Allergan plc), Daewoong Pharmaceutical Co., Ltd., Evolus Inc., Galderma S.A., HUGEL Inc., Ipsen S.A., Lanzhou Institute of Biological Products Co., Ltd., Medy-Tox Inc., Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., US WorldMeds LLC, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global botulinum toxin market.
- To classify and forecast the global botulinum toxin market based on product, application, end user, region.
- To identify drivers and challenges for the global botulinum toxin market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global botulinum toxin market.
- To identify and analyze the profile of leading players operating in the global botulinum toxin market.
Why Choose This Report
- Gain a reliable outlook of the global botulinum toxin market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
Type A botulinum toxin
Type B botulinum toxin
PART 6. MARKET BREAKDOWN BY APPLICATION
Aesthetic
Medical
PART 7. MARKET BREAKDOWN BY END USER
Hospitals
Specialty and dermatology clinics
Others
PART 8. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 9. KEY COMPANIES
AbbVie Inc. (Allergan plc)
Daewoong Pharmaceutical Co., Ltd.
Evolus Inc.
Galderma S.A.
HUGEL Inc.
Ipsen S.A.
Lanzhou Institute of Biological Products Co., Ltd.
Medy-Tox Inc.
Merz Pharma GmbH & Co. KGaA
Revance Therapeutics Inc.
US WorldMeds LLC
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Global Whole Exome Sequencing Market 2023
DescriptionThe Whole Exome Sequencing Market is poised for substantial growth, with a projected increase from USD 1.43 billion in 2022 to USD 3.75 billion by 2029. This growth is expected
USD 1950 View ReportGlobal Continuous Bioprocessing Market 2023
DescriptionThe global Continuous Bioprocessing Market size is anticipated to expand from USD 133.9 million in 2022 to USD 443.1 million by 2029, registering a compound annual growth rate (CAGR) of
USD 1950 View ReportCOVID-19 Outbreak-Global Botulinum Toxin Type A Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Botulinum Toxin Type A market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak
USD 3660 View ReportCOVID-19 Outbreak-Global Botulinum Neurotoxins Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Botulinum Neurotoxins market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak globally, this
USD 3660 View ReportFill The Form For Sample Request